首页> 外文OA文献 >Concurrent Cetuximab Is Associated With Decreased Overall Survival In Patients With Locally Advanced Head And Neck Cancer Receiving Definitive Radiotherapy: A National Cancer Database Analysis

【2h】

Concurrent Cetuximab Is Associated With Decreased Overall Survival In Patients With Locally Advanced Head And Neck Cancer Receiving Definitive Radiotherapy: A National Cancer Database Analysis

机译：同时的西妥昔单抗与局部先进的头部和颈部癌症接受过度放射治疗的患者的整体存活率下降有关：国家癌症数据库分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
M.C. Korpics; M. Koshy; M.T. Spiotto;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Survival of patients with head and neck cancer treated with definitive radiotherapy and concurrent cisplatin or concurrent cetuximab: A Surveillance, Epidemiology, and End Results-Medicare analysis [J] . Xiang Michael, Holsinger F. Christopher, Colevas A. Dimitrios, Cancer: A Journal of the American Cancer Society . 2018,第23期

机译：患有明确放疗和同时顺铂或同时的颈部癌症患者的存活：一种监测，流行病学和最终结果 - Medicare分析
2. Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer. [J] . Argiris A, Heron DE, Smith RP, Journal of Clinical Oncology . 2010,第36期

机译：对于局部晚期头颈癌患者，先诱导多西紫杉醇，顺铂和西妥昔单抗，然后同时放疗，顺铂和西妥昔单抗并维持西妥昔单抗。
3. Cost effectiveness of cetuximab concurrent with radiotherapy for patients with locally advanced head and neck cancer in Taiwan: a decision-tree analysis. [J] . Chan AL, Leung HW, Huang SF Clinical drug investigation . 2011,第10期

机译：西妥昔单抗联合放疗在台湾局部晚期头颈癌患者中的成本效益：决策树分析。
4. Survival prediction of squamous cell head and neck cancer patients based on radiomic features selected from lung cancer patients using artificial neural network [C] . H. Kamezawa, H. Arimura, M. Soufi SPIE Medical Imaging Conference . 2018

机译：利用人工神经网络从肺癌患者的放射学特征中预测鳞状细胞癌的生存率
5. Symptoms, symptom distress, depressive symptoms, and uncertainty in newly diagnosed head and neck cancer patients receiving definitive radiotherapy with or without chemotherapy [D] . Haisfield-Wolfe, Mary Ellen 2009

机译：新诊断头颈癌患者接受明确放疗并伴或不伴化疗的症状，症状困扰，抑郁症状和不确定性
6. Induction Docetaxel Cisplatin and Cetuximab Followed by Concurrent Radiotherapy Cisplatin and Cetuximab and Maintenance Cetuximab in Patients With Locally Advanced Head and Neck Cancer [O] . Athanassios Argiris, Dwight E. Heron, Ryan P. Smith, -1

机译：局部晚期头颈癌患者中诱导多西他赛顺铂和西妥昔单抗的治疗随后进行放射疗法顺铂和西妥昔单抗的维持治疗及西妥昔单抗的维持
7. Survival of patients with head and neck cancer treated with definitive radiotherapy and concurrent cisplatin or concurrent cetuximab: A Surveillance, Epidemiology, and End Results‐Medicare analysis [O] . Michael Xiang, F. Christopher Holsinger, A. Dimitrios Colevas, 2018

机译：患有明确放疗和同时顺铂或同时的颈部癌症患者的生存患者或同时的甲磺蛋白：监测，流行病学和最终结果 - Medicare分析

Concurrent Cetuximab Is Associated With Decreased Overall Survival In Patients With Locally Advanced Head And Neck Cancer Receiving Definitive Radiotherapy: A National Cancer Database Analysis

著录项

引文网络

相似文献

相关主题

期刊订阅